The North America Implantable Cardioverter Defibrillator Market would witness market growth of 5.4% CAGR during the forecast period (2023-2030).
Technological advances and product innovations, such as Epsila EV MRI SureScan and Aurora Extravascular (EV)-ICD MRI SureScan by Medtronic, offer optimistic solutions with reduced complications and enhanced placement techniques. Moreover, the prevalence of sudden cardiac arrest is on the rise in emerging nations. The prevalence of sudden cardiac arrest is anticipated to rise due to the growth of specific risk factors like smoking, obesity, and sedentary lifestyle, which is anticipated to raise demand for ICD during the forecast period.
The ICD has seen continuous technological advancements, leading to smaller, more efficient devices with improved battery life. These advancements have made ICDs more comfortable for patients and easier for healthcare providers to implant. Miniaturization of ICDs has been a significant trend, allowing for less invasive procedures and reduced scarring. Smaller devices also improve patient comfort and reduce the risk of infection. Remote monitoring capabilities have become increasingly important in ICDs. These devices can transmit data and alerts to healthcare providers, allowing for proactive patient care and early detection of potential issues.
North America has a significant prevalence of cardiovascular diseases, including arrhythmias, heart failure, and coronary artery disease. ICDs are essential in preventing sudden cardiac death in patients with these conditions. North America is known for its advanced medical technology and innovation. Manufacturers in the region and around the world develop state-of-the-art ICDs with features such as remote monitoring, MRI compatibility, and sophisticated algorithms for arrhythmia detection. The adoption and utilization of ICDs in North America continue to grow as healthcare providers and patients recognize the value of these devices in managing cardiac conditions and reducing the risk of sudden cardiac death. Advances in technology, research, and patient care contribute to the ongoing development of the ICD in the region.
The US market dominated the North America Implantable Cardioverter Defibrillator Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,554.6 million by 2030. The Canada market is exhibiting a CAGR of 7.8% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 6.9% during (2023 - 2030).
Based on Type, the market is segmented into Biventricular Devices, Dual Chamber ICDs and Single Chamber ICDs. Based on Product Type, the market is segmented into Transvenous and Subcutaneous. Based on NYHA Class, the market is segmented into NYHA Class II and NYHA Class III. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Implantable Cardioverter Defibrillator Market is Predict to reach $5.6 Billion by 2030, at a CAGR of 6.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Biotronik SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, Stryker Corporation, ZOLL Medical Corporation (Asahi Kasei Corporation), LivaNova PLC, Koninklijke Philips N.V. and Getinge AB.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Biventricular Devices
- Dual Chamber ICDs
- Single Chamber ICDs
By Product Type
By NYHA Class
- NYHA Class II
- NYHA Class III
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Medtronic PLC
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Stryker Corporation
- ZOLL Medical Corporation (Asahi Kasei Corporation)
- LivaNova PLC
- Koninklijke Philips N.V.
- Getinge AB
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Implantable Cardioverter Defibrillator Market, by Type
1.4.2 North America Implantable Cardioverter Defibrillator Market, by Product Type
1.4.3 North America Implantable Cardioverter Defibrillator Market, by NYHA Class
1.4.4 North America Implantable Cardioverter Defibrillator Market, by End-use
1.4.5 North America Implantable Cardioverter Defibrillator Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Implantable Cardioverter Defibrillator Market
Chapter 5. North America Implantable Cardioverter Defibrillator Market, By Type
5.1 North America Biventricular Devices Market, By Country
5.2 North America Dual Chamber ICDs Market, By Country
5.3 North America Single Chamber ICDs Market, By Country
Chapter 6. North America Implantable Cardioverter Defibrillator Market, By Product Type
6.1 North America Transvenous Market, By Country
6.2 North America Subcutaneous Market, By Country
Chapter 7. North America Implantable Cardioverter Defibrillator Market, By NYHA Class
7.1 North America NYHA Class II Market, By Country
7.2 North America NYHA Class III Market, By Country
Chapter 8. North America Implantable Cardioverter Defibrillator Market, By End-use
8.1 North America Hospitals Market, By Country
8.2 North America Ambulatory Surgical Centers Market, By Country
8.3 North America Others Market, By Country
Chapter 9. North America Implantable Cardioverter Defibrillator Market, By Country
9.1 US Implantable Cardioverter Defibrillator Market
9.1.1 US Implantable Cardioverter Defibrillator Market, By Type
9.1.2 US Implantable Cardioverter Defibrillator Market, By Product Type
9.1.3 US Implantable Cardioverter Defibrillator Market, By NYHA Class
9.1.4 US Implantable Cardioverter Defibrillator Market, By End-use
9.2 Canada Implantable Cardioverter Defibrillator Market
9.2.1 Canada Implantable Cardioverter Defibrillator Market, By Type
9.2.2 Canada Implantable Cardioverter Defibrillator Market, By Product Type
9.2.3 Canada Implantable Cardioverter Defibrillator Market, By NYHA Class
9.2.4 Canada Implantable Cardioverter Defibrillator Market, By End-use
9.3 Mexico Implantable Cardioverter Defibrillator Market
9.3.1 Mexico Implantable Cardioverter Defibrillator Market, By Type
9.3.2 Mexico Implantable Cardioverter Defibrillator Market, By Product Type
9.3.3 Mexico Implantable Cardioverter Defibrillator Market, By NYHA Class
9.3.4 Mexico Implantable Cardioverter Defibrillator Market, By End-use
9.4 Rest of North America Implantable Cardioverter Defibrillator Market
9.4.1 Rest of North America Implantable Cardioverter Defibrillator Market, By Type
9.4.2 Rest of North America Implantable Cardioverter Defibrillator Market, By Product Type
9.4.3 Rest of North America Implantable Cardioverter Defibrillator Market, By NYHA Class
9.4.4 Rest of North America Implantable Cardioverter Defibrillator Market, By End-use
Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.5.2 Trails and Approvals:
10.1.6 SWOT Analysis
10.2 Medtronic PLC
10.2.1 Company overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 SWOT Analysis
10.3 Biotronik SE & Co. KG
10.3.1 Company Overview
10.3.2 SWOT Analysis
10.4 Boston Scientific Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 SWOT Analysis
10.5 MicroPort Scientific Corporation
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 SWOT Analysis
10.6 Stryker Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.6.6 SWOT Analysis
10.7 ZOLL Medical Corporation (Asahi Kasei Corporation)
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Acquisition and Mergers:
10.7.6 SWOT Analysis
10.8 LivaNova PLC
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.8.5 SWOT Analysis
10.9 Koninklijke Philips N.V.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Acquisition and Mergers:
10.9.6 SWOT Analysis
10.10. Getinge AB
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 SWOT Analysis
TABLE 1 North America Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 2 North America Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 3 North America Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 4 North America Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 5 North America Biventricular Devices Market, By Country, 2019 - 2022, USD Million
TABLE 6 North America Biventricular Devices Market, By Country, 2023 - 2030, USD Million
TABLE 7 North America Dual Chamber ICDs Market, By Country, 2019 - 2022, USD Million
TABLE 8 North America Dual Chamber ICDs Market, By Country, 2023 - 2030, USD Million
TABLE 9 North America Single Chamber ICDs Market, By Country, 2019 - 2022, USD Million
TABLE 10 North America Single Chamber ICDs Market, By Country, 2023 - 2030, USD Million
TABLE 11 North America Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 12 North America Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 13 North America Transvenous Market, By Country, 2019 - 2022, USD Million
TABLE 14 North America Transvenous Market, By Country, 2023 - 2030, USD Million
TABLE 15 North America Subcutaneous Market, By Country, 2019 - 2022, USD Million
TABLE 16 North America Subcutaneous Market, By Country, 2023 - 2030, USD Million
TABLE 17 North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 18 North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 19 North America NYHA Class II Market, By Country, 2019 - 2022, USD Million
TABLE 20 North America NYHA Class II Market, By Country, 2023 - 2030, USD Million
TABLE 21 North America NYHA Class III Market, By Country, 2019 - 2022, USD Million
TABLE 22 North America NYHA Class III Market, By Country, 2023 - 2030, USD Million
TABLE 23 North America Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 24 North America Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 25 North America Hospitals Market, By Country, 2019 - 2022, USD Million
TABLE 26 North America Hospitals Market, By Country, 2023 - 2030, USD Million
TABLE 27 North America Ambulatory Surgical Centers Market, By Country, 2019 - 2022, USD Million
TABLE 28 North America Ambulatory Surgical Centers Market, By Country, 2023 - 2030, USD Million
TABLE 29 North America Others Market, By Country, 2019 - 2022, USD Million
TABLE 30 North America Others Market, By Country, 2023 - 2030, USD Million
TABLE 31 North America Implantable Cardioverter Defibrillator Market, By Country, 2019 - 2022, USD Million
TABLE 32 North America Implantable Cardioverter Defibrillator Market, By Country, 2023 - 2030, USD Million
TABLE 33 US Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 34 US Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 35 US Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 36 US Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 37 US Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 38 US Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 39 US Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 40 US Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 41 US Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 42 US Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 43 Canada Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 44 Canada Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 45 Canada Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 46 Canada Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 47 Canada Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 48 Canada Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 49 Canada Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 50 Canada Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 51 Canada Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 52 Canada Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 53 Mexico Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 54 Mexico Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 55 Mexico Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 56 Mexico Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 57 Mexico Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 58 Mexico Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 59 Mexico Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 60 Mexico Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 61 Mexico Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 62 Mexico Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 63 Rest of North America Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 64 Rest of North America Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 65 Rest of North America Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 66 Rest of North America Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 67 Rest of North America Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 68 Rest of North America Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 69 Rest of North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 70 Rest of North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 71 Rest of North America Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 72 Rest of North America Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 73 Key Information – Abbott Laboratories
TABLE 74 Key Information – Medtronic PLC
TABLE 75 Key Information – Biotronik SE & Co. KG
TABLE 76 Key Information – Boston Scientific Corporation
TABLE 77 key Information – MicroPort Scientific Corporation
TABLE 78 Key Information – Stryker Corporation
TABLE 79 Key Information – ZOLL Medical Corporation
TABLE 80 Key Information – LivaNova PLC
TABLE 81 Key Information – Koninklijke Philips N.V.
TABLE 82 Key Information – Getinge AB
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Implantable Cardioverter Defibrillator Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Implantable Cardioverter Defibrillator Market
FIG 4 Porter’s Five Forces Analysis – Implantable Cardioverter Defibrillator Market
FIG 5 North America Implantable Cardioverter Defibrillator Market share, By Type, 2022
FIG 6 North America Implantable Cardioverter Defibrillator Market share, By Type, 2030
FIG 7 North America Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2030, USD Million
FIG 8 North America Implantable Cardioverter Defibrillator Market share, By Product Type, 2022
FIG 9 North America Implantable Cardioverter Defibrillator Market share, By Product Type, 2030
FIG 10 North America Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2030, USD Million
FIG 11 North America Implantable Cardioverter Defibrillator Market share, By NYHA Class, 2022
FIG 12 North America Implantable Cardioverter Defibrillator Market share, By NYHA Class, 2030
FIG 13 North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2030, USD Million
FIG 14 North America Implantable Cardioverter Defibrillator Market share, By End-use, 2022
FIG 15 North America Implantable Cardioverter Defibrillator Market share, By End-use, 2030
FIG 16 North America Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2030, USD Million
FIG 17 North America Implantable Cardioverter Defibrillator Market share, By Country, 2022
FIG 18 North America Implantable Cardioverter Defibrillator Market share, By Country, 2030
FIG 19 North America Implantable Cardioverter Defibrillator Market, By Country, 2019 - 2030, USD Million
FIG 20 Recent strategies and developments: ABBOTT LABORATORIES
FIG 21 SWOT Analysis: Abbott Laboratories
FIG 22 SWOT Analysis: Medtronic PLC
FIG 23 SWOT Analysis: Biotronik SE & Co. KG
FIG 24 SWOT Analysis: Boston Scientific Corporation
FIG 25 SWOT Analysis: MicroPort Scientific Corporation
FIG 26 SWOT Analysis: Stryker Corporation
FIG 27 SWOT Analysis: ZOLL Medical Corporation
FIG 28 SWOT Analysis: LivaNova PLC
FIG 29 SWOT Analysis: Koninklijke Philips N.V.
FIG 30 SWOT Analysis: Getinge AB